Form 4 Tracker
Jason Hoitt

Chief Patient Officer · 2 filings · Latest: Mar 17, 2026

Stoke Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
STOK
Jason HoittChief Patient OfficerMar 18, 2026
Sale
$31.341,931$60.5K10,276
STOK
Jason HoittChief Patient OfficerMar 17, 2026
Sale
$33.011,781$58.8K12,207
STOK
Jason HoittChief Patient OfficerMar 15, 2026
Option Exercise
$0.0010,00013,988